ALPHA TRIBE

Dr. Lal Path Labs Ltd.Updates, 31-10-2025: Press Release

31-10-2025 | 02:35 pm

Dr Lal PathLabs reported Q2 FY26 revenue of Rs 731 Cr (+10.7%), with EBITDA up 10.8% and PAT up 16.4%. The Board approved a 1:1 bonus share issue and declared an interim dividend of Rs 7 per share.

No comments yet. Be the first to comment!

All announcements from Dr. Lal Path Labs Ltd.